» Authors » Magdalena Holeckova

Magdalena Holeckova

Explore the profile of Magdalena Holeckova including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 121
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kacerovsky M, Hornychova H, Holeckova M, Pavlikova L, Rezabkova Chloubova J, Jacobsson B, et al.
Fetal Diagn Ther . 2024 Jul; 51(6):539-549. PMID: 38964308
Introduction: The aim of the study was to identify predictive values of the soluble fms-like tyrosine kinase/placental growth factor (sFlt-1/PlGF) ratio and interleukin (IL)-6, assessed with a clinically available method...
2.
Kacerovsky M, Hornychova H, Jaiman S, Pavlikova L, Holeckova M, Jacobsson B, et al.
Acta Obstet Gynecol Scand . 2024 Mar; 103(6):1120-1131. PMID: 38511515
Introduction: This study aimed to identify whether microbial invasion of the amniotic cavity and/or intra-amniotic inflammation in women with late preterm prelabor rupture of membranes (PPROM) was associated with changes...
3.
Musilova I, Pavlikova L, Holeckova M, Kremlacek J, Jacobsson B, Kacerovsky M
Am J Obstet Gynecol . 2024 Mar; 231(1):e26-e30. PMID: 38432410
No abstract available.
4.
Musilova I, Kremlacek J, Pavlikova L, Holeckova M, Volnerova M, Jacobsson B, et al.
Am J Obstet Gynecol . 2023 Nov; 230(4):e38-e42. PMID: 37977242
No abstract available.
5.
Pokorna Z, Kollarova-Brazdova P, Lencova-Popelova O, Jirkovsky E, Kubes J, Mazurova Y, et al.
Clin Sci (Lond) . 2021 Dec; 136(1):139-161. PMID: 34878093
Angiotensin-converting enzyme inhibitors (ACEis) have been used to treat anthracycline (ANT)-induced cardiac dysfunction, and they appear beneficial for secondary prevention in high-risk patients. However, it remains unclear whether they truly...
6.
Kollarova-Brazdova P, Lencova-Popelova O, Karabanovich G, Kocurova-Lengvarska J, Kubes J, Vanova N, et al.
Clin Sci (Lond) . 2021 Jul; 135(15):1897-1914. PMID: 34318878
The anthracycline (ANT) anticancer drugs such as doxorubicin or daunorubicin (DAU) can cause serious myocardial injury and chronic cardiac dysfunction in cancer survivors. A bisdioxopiperazine agent dexrazoxane (DEX) has been...
7.
Cobo T, Aldecoa V, Holeckova M, Andrys C, Filella X, Jacobsson B, et al.
Fetal Diagn Ther . 2021 Apr; 48(5):327-332. PMID: 33902036
Objectives: A multivariable predictive model has recently been developed with good accuracy to predict spontaneous preterm delivery within 7 days in women with preterm labor (PTL) and intact membranes. However,...
8.
Stranik J, Kacerovsky M, Andrys C, Soucek O, Bolehovska R, Holeckova M, et al.
J Matern Fetal Neonatal Med . 2021 Jan; 35(25):4861-4869. PMID: 33412979
Objective: To determine the concentration of interleukin-6 (IL-6) in the cervical fluid in women with spontaneous preterm labor with intact fetal membranes (PTL) complicated by intra-amniotic infection (the presence of...
9.
Kacerovsky M, Holeckova M, Stepan M, Gregor M, Vescicik P, Lesko D, et al.
J Matern Fetal Neonatal Med . 2020 Jun; 35(12):2247-2259. PMID: 32580603
Introduction: To determine the amniotic fluid glucose levels in pregnancies complicated by preterm prelabor rupture of membranes (PPROM) based on the presence of microbial invasion of the amniotic cavity and/or...
10.
Musilova I, Andrys C, Holeckova M, Kolarova V, Pliskova L, Drahosova M, et al.
J Matern Fetal Neonatal Med . 2018 Oct; 33(11):1919-1926. PMID: 30293462
We aimed to compare the amniotic fluid interleukin (IL)-6 concentrations measured using the automated electrochemiluminescence immunoassay method and ELISA, and to establish an IL-6 concentration cut-off value for intra-amniotic inflammation...